Research and Markets: Examine Core Business Activities of Medtronic with This Medical Device Company Intelligence Report.
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
Medtronic, headquartered in Minneapolis, Minnesota, USA, is a medical technology company specialised in implantable and interventional therapies. Over the last five years, Medtronic's revenue has more than doubled, rising from US$5 billion in fiscal 2000 to over US$11 billion in fiscal 2006,.
Medtronic's products are organised within seven operating segments:
Cardiac Rhythm Disease Management - Medtronic's largest operating division, accounting for 46% of the company's total revenue in fiscal 2006. Products include cardiac resynchronisation therapy (CRT) devices, pacemakers, implantable and external defibrillators, leads and ablation products.
Vascular - Includes drug-eluting and other coronary stents, balloon and guiding catheters, endovascular stent grafts, embolic protection products and peripheral vascular products. In fiscal 2006, sales from this division accounted for 8% of Medtronic's total revenue.
Cardiac Surgery - Includes perfusion systems, heart valves, minimally-invasive cardiac surgery products and accessories. In fiscal 2006, sales from the segment accounted for 6% of Medtronic's revenue.
Spinal and Navigation - Includes thoracolumbar, cervical and interbody spinal devices and surgical navigation tools. Revenue from the segment accounted for 20% of Medtronic's sales in fiscal 2006.
Neurological - Includes implantable neurostimulation devices, implantable drug administration systems and Medtronic's obesity management products. The division generated 9% of Medtronic's revenue in fiscal 2006.
Diabetes - Includes systems for the treatment of diabetes. The division generated 6% of Medtronic's revenue in fiscal 2006.
ENT - Includes surgical products used by ENT physicians and neurology products. Revenue from the segment accounted for 4% of Medtronic's sales in fiscal 2006."
Key Topics Covered Include:
* Product Portfolio and R&D
* Revenue by Operating Segment, 2004-2006 (US$ million)
* Cardiac Rhythm Disease Management
* Implantable Defibrillators
* Pacing Products
* Patient Management
* External Defibrillators
* Electrophysiology (EP) Systems
* Coronary Products
* Endovascular and Peripheral Products
* Heart Valves and Repair Products
* Surgical Ablation
* Spinal Products
* Neurological Products
* Gastroenterology and Urology
* Diabetes Market
* Powered Surgical Systems
* Otology/Neurotology Products
* Rhinology Products
* Plastic Surgery Products
* Powered Surgical Systems
* Endoscopy Products
* Nerve Integrity Monitoring Systems
For more information visit http://www.researchandmarkets.com/reports/c43647
|Printer friendly Cite/link Email Feedback|
|Date:||Oct 16, 2006|
|Previous Article:||$50+ Million Dollar / 70 Well Drilling Program Continues Its Success As Three (3) More Wells Strike Oil on ACOR's ORRI under ATP-299.|
|Next Article:||Research and Markets: Learn about Danaher's New Medical Technology Business Which Forms Part of the Company's Professional Instrumentation Segment.|